Sitemap
|
Search
|
Glossary
|
Terms
|
Contact
|
Deutsch
Company
Diagnostic Products
Research Products
Biomarker Services
Science & Technology
Investor Relations
Newsroom
Downloads
Career
Imprint
Sitemap
Glossary
Terms
Contact
print page
PDF
A
B
C
D
E
F
G
H
I
L
M
O
P
Q
R
S
T
V
A
ASR
Adjuvant treatment
Amplification
Array
Assay
Asymptomatic
B
BCR
Bases
BfArM
Biochip
Biomarker
Biomarker Panel
Biopsy
Bisulfite
Bisulfite Sequencing
C
CE-mark
CE-marking
CLIA
CMS
CPT
CSIRO
Carcinoma
Center for Devices and Radiological Health
Chip
Classification
Colonoscopy
Concept
CpG
D
DNA (Desoxyribonucleic acid)
DNA Microarrays
DNA Sequences
DNA methylation
DRE
Diagnostics
E
Epigenomics
Expression
F
FDA
FFDCA
FOB
FOBT
False negative results
False positive results
G
GMP
Gene
Gene Activity
Gene regulation
Genome
Genomics
Gleason score
Gold Standard
H
Histology
I
IDE
IP
IRB
IVD
IVD platform.
IVD-Directive
Immunoassay
In-vitro
In-vivo
Indication
Installed base
L
LAGetSI
Lesion
M
MSP
Metastasis
Methyl group
Methylation
Microarray
Molecular diagnostics.
Monitoring
Morbidity
Mortality
mRNA
O
OEM
Oncology
P
PCR
PCT
PMA
PRESEPT Study
PSA
Paraffin
Pharmacodiagnostics
Platform
Polymerase
Primer
Primer Extension
Prognosis
Proof-of-Concept
Protein
Proteomics
Q
QSR
R
R&D
RNA
RUO
Reference laboratory
Research market
S
SBU or SBUs
Screening
Sensitivity
Sigmoidoscopy
Specificity
Surveillance
T
Tamoxifen
Test kit
Tumor
V
Validation
top of the page
